Effect of nocturnal oxygen and acetazolamide on exercise performance in patients with precapillary pulmonary hypertension and sleep disturbed breathing. Randomized, double-blind, cross-over trial

S. Ulrich, S. Keusch, F. Hildenbrand, C. Lo Casio, L. Huber, F. Tanner, R. Speich, K. Bloch (Zurich, Switzerland)

Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Session: Pulmonary circulation: clinical treatment
Session type: Thematic Poster Session
Number: 4066
Disease area: Pulmonary vascular diseases, Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Ulrich, S. Keusch, F. Hildenbrand, C. Lo Casio, L. Huber, F. Tanner, R. Speich, K. Bloch (Zurich, Switzerland). Effect of nocturnal oxygen and acetazolamide on exercise performance in patients with precapillary pulmonary hypertension and sleep disturbed breathing. Randomized, double-blind, cross-over trial. Eur Respir J 2013; 42: Suppl. 57, 4066

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – A prospective, randomized, controlled trial
Source: International Congress 2016 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2016


Acute hemodynamic effect of acetazolamide in patients with pulmonary hypertension whilst breathing normoxic and hypoxic air: a randomized cross-over trial
Source: Virtual Congress 2021 – Therapy of pulmonary hypertension
Year: 2021


Effect of high-flow oxygen therapy on exercise tolerance in idiopathic pulmonary fibrosis: a randomized crossover trial.
Source: Virtual Congress 2021 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2021



Effect of long-term oxygen therapy on exercise capacity and quality of life in exercise-desaturating patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomized-sham-controlled cross-over trial
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017

Randomized, controlled, prospective multicenter study: Training improves peak oxygen consumption and hemodynamics in patients with chronic severe pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: improving treatment in PAH
Year: 2014


Effect of macitentan on haemodynamics in SERAPHIN, a randomised controlled trial in pulmonary arterial hypertension (PAH)
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013


Hyperoxia enhances exercise performance in PAH and CTEPH: Randomized trial
Source: International Congress 2016 – Clinic of pulmonary hypertension
Year: 2016

Randomized placebo-controlled trial: effects of continuous positive airway pressure in patients with hypertension ²non dipper² without treatment and obstructive sleep apnea
Source: Eur Respir J 2005; 26: Suppl. 49, 723s
Year: 2005

Effect of breathing oxygen-enriched air on exercise performance in patients with pulmonary hypertension in heart failure with preserved ejection fraction. Randomized, placebo-controlled, cross-over trial.
Source: Virtual Congress 2021 – Non-pulmonary arterial hypertension pulmonary hypertension
Year: 2021



Effects of inspiratory muscle training on the sensation of dyspnea in patients with pulmonary hypertension group I and IV - Randomized controlled clinical trial
Source: International Congress 2018 – Respiratory muscle function, postural control and breathing exercises in chronic respiratory conditions
Year: 2018

Effectiveness of non-invasive ventilation in stable chronic obstructive pulmonary disease with nocturnal desaturation: Prospective open-label randomized parallel-group study
Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes
Year: 2013


Acute improvement of pulmonary hemodynamics does not alleviate Cheyne-Stokes respiration in chronic heart failure - a randomized, controlled, double-blind, crossover trial
Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing
Year: 2013

Domiciliary high-flow nasal cannula oxygen therapy for stable hypercapnic chronic obstructive pulmonary disease: a prospective, multicentre, randomised crossover trial
Source: International Congress 2017 – New insights in chronic respiratory failure
Year: 2017



Effect of nocturnal oxygen therapy on daytime pulmonary hemodynamics in patients with COPD travelling to altitude. RCT.
Source: Virtual Congress 2021 – Treatments for airway diseases
Year: 2021


Effect of acetazolamide on pulmonary hemodynamics in COPD-patients going to altitude: a randomized trial
Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension
Year: 2019

Dexamethasone reduces pulmonary artery pressure in lowlanders with COPD travelling to 3200m. A randomized, placebo-controlled trial
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016

Late Breaking Abstract - Effect of oxygen supplementation on sleep and nocturnal breathing in patients with chronic obstructive pulmonary disease travelling to high altitude: randomized trial
Source: International Congress 2018 – What’s new in lung function and exercise assessment in COPD?
Year: 2018



Effect of hyperoxia on exercise performance in COPD: Randomized trial
Source: International Congress 2016 – Unmasking the mechanisms of symptoms and exercise limitation in disease
Year: 2016


Effects of suboptimal adherence of CPAP therapy on symptoms of obstructive sleep apnoea: a randomised, double-blind, controlled trial
Source: Eur Respir J, 55 (3) 1901526; 10.1183/13993003.01526-2019
Year: 2020



Randomised controlled, crossover trial to evaluate the effects of ambulatory oxygen on health status in patients with fibrotic lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016